Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Teva Pharmaceutical Industries ADR (NY: TEVA ) 16.36 -0.04 (-0.24%) Official Closing Price Updated: 7:00 PM EDT, Jul 8, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 5,806,292 Open 16.50 Bid (Size) 16.26 (2) Ask (Size) 16.75 (5) Prev. Close 16.40 Today's Range 16.32 - 16.60 52wk Range 7.800 - 17.69 Shares Outstanding 1,110,352,397 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Teva to Host Conference Call to Discuss Second Quarter 2024 Financial Results at 8 a.m. ET on July 31, 2024 July 02, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire FTC Crackdown on Teva Pharmaceuticals Over Inhaler Patent Abuse July 01, 2024 The FTC is investigating Teva Pharmaceuticals for alleged misuse of inhaler patents to block generic competition and maintain high prices in the U.S. while selling the same products for less overseas. Via Benzinga Topics Intellectual Property Exposures Intellectual Property Performance YTD +53.33% +53.33% 1 Month -2.91% -2.91% 3 Month +15.21% +15.21% 6 Month +42.63% +42.63% 1 Year +107.09% +107.09% More News Read More Dr. Reddy's Labs Stock Sees Improved Technical Strength June 28, 2024 Via Investor's Business Daily New AJOVY® (fremanezumab) Migraine Prevention Data Challenges Treatment Pauses June 28, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Breaking Down Teva Pharmaceutical Indus: 5 Analysts Share Their Views June 27, 2024 Via Benzinga If You Invested $1000 In This Stock 5 Years Ago, You Would Have $2,100 Today June 12, 2024 Via Benzinga 4 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know May 30, 2024 Via Benzinga Teva Reaches Agreement With the Israel Tax Authority to Resolve All Pending Litigation for the Company's Taxable Years 2008-2020 June 25, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva Announces Launch of Authorized Generic of Victoza® (liraglutide injection 1.8mg), in the United States June 24, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva Engages In Settlement Talks Over Medicare Kickback Allegations June 18, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Concerpt Therapeutics Shares Are Trading Lower: What You Need To Know June 14, 2024 Via Benzinga Topics Lawsuit Exposures Financial Legal Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know May 22, 2024 Via Benzinga 7 A-Rated Biotech Stocks Worth Betting on in June June 14, 2024 Via InvestorPlace What is a Bull Flag Pattern? Explanation and Examples June 13, 2024 Via MarketBeat Teva to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 04, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire New Data Provide Schizophrenia Treatment Insights into Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension from Invega Sustenna® (paliperidone palmitate) June 01, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva Presents First Real-World Data from the IMPACT-TD Registry Study at Psych Congress Elevate 2024 June 01, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire 2 Generic Drug Makers With Growing Runways May 31, 2024 Via MarketBeat Topics Intellectual Property Exposures Intellectual Property Teva Announces AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets Now U.S. FDA Approved as a One Pill, Once-Daily Treatment Option for Clinically Therapeutic Doses (24–48 mg/day) May 29, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. May 20, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S. May 20, 2024 From Alvotech Via GlobeNewswire Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch May 18, 2024 Via Benzinga Topics Cannabis Exposures Cannabis Patent Peril: 3 Stocks at Risk From the FTC’s Drug Crusade May 16, 2024 Via InvestorPlace Topics Intellectual Property Exposures Intellectual Property Teva Announces Appointment of Matthew Shields to Executive Vice President, Teva Global Operations May 15, 2024 From Teva Pharmaceutical Industries Limited Via Business Wire These 10 Large Cap Stocks Shined Brightest Last Week (May 5-May 11, 2024): Are They In Your Portfolio? May 12, 2024 Via Benzinga Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.